We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.55B
AUM Growth
-$172M
Cap. Flow
+$97.5M
Cap. Flow %
1.76%
Top 10 Hldgs %
18.08%
Holding
1,627
New
142
Increased
661
Reduced
568
Closed
164

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$12.9M
2
SGOL icon
abrdn Physical Gold Shares ETF
SGOL
+$12.4M
3
TIPX icon
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
+$12.2M
4
MSFT icon
Microsoft
MSFT
+$10.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$8.73M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$18M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$17.6M
3
XLNX
Xilinx Inc
XLNX
+$7.92M
4
GTO icon
Invesco Total Return Bond ETF
GTO
+$7.49M
5
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$7.46M

Sector Composition

Rank Sector Weight
1 Technology 17.91%
2 Financials 11.7%
3 Healthcare 10.28%
4 Industrials 8.25%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SURF
1451
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$32K ﹤0.01%
11,049
– –
SENS icon
1452
Senseonics Holdings Inc
SENS
$265M
$30K ﹤0.01%
750
– –
NBSE
1453
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$30K ﹤0.01%
788
– –
GEG icon
1454
Great Elm Group
GEG
$68.4M
$24K ﹤0.01%
13,091
-1,644
-11% -$3.21K
WRN
1455
Western Copper and Gold
WRN
$476M
$24K ﹤0.01%
10,000
– –
MREO
1456
Mereo BioPharma
MREO
$50.3M
$22K ﹤0.01%
20,000
– –
VCNX
1457
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$19K ﹤0.01%
68
– –
WATT icon
1458
Energous
WATT
$77.2M
$18K ﹤0.01%
25
– –
DFTX
1459
Definium Therapeutics
DFTX
$5.91B
$14K ﹤0.01%
+855
New +$14.8K
AMPE
1460
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$12K ﹤0.01%
84
– –
ORTX
1461
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$8K ﹤0.01%
+1,160
New +$11.4K
DMK
1462
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$7K ﹤0.01%
171
– –
TXMD icon
1463
TherapeuticsMD
TXMD
$23.5M
$4K ﹤0.01%
+244
New +$3.84K
AAP icon
1464
Advance Auto Parts
AAP
$3.39B
– –
-1,091
Closed -$262K
ACA icon
1465
Arcosa
ACA
$7.13B
– –
-12,968
Closed -$683K
AEG icon
1466
Aegon
AEG
$14B
– –
-10,752
Closed -$51K
AFRM icon
1467
Affirm
AFRM
$24.5B
– –
-2,420
Closed -$243K
AGZ icon
1468
iShares Agency Bond ETF
AGZ
$559M
– –
-16,749
Closed -$1.96M
AI icon
1469
C3.ai
AI
$1.41B
– –
-22,399
Closed -$700K
ALGN icon
1470
Align Technology
ALGN
$12.4B
– –
-351
Closed -$231K
AMN icon
1471
AMN Healthcare
AMN
$1.35B
– –
-2,675
Closed -$327K
AOK icon
1472
iShares Core Conservative Allocation ETF
AOK
$788M
– –
-16,739
Closed -$670K
AOM icon
1473
iShares Core Moderate Allocation ETF
AOM
$1.75B
– –
-14,775
Closed -$672K
APOG icon
1474
Apogee Enterprises
APOG
$832M
– –
-55,025
Closed -$2.65M
ARKQ icon
1475
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.88B
– –
-4,234
Closed -$326K
57 58
59
60 61

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Oppenheimer & Co held 1,627 positions worth $5.55B, down 3% from $5.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q1 2022 filing shows 142 new, 661 increased, 568 reduced and 164 closed positions. Its largest new stake was abrdn Physical Gold Shares ETF: 689,377 shares worth $12.8M. The largest sale was Apple, an estimated $18M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q1 2022 buy was abrdn Physical Gold Shares ETF: 689,377 shares worth $12.8M.
  • Oppenheimer & Co added most to Citigroup in Q1 2022, an estimated $12.9M increase.
  • Oppenheimer & Co's biggest Q1 2022 reduction was Apple, cutting an estimated $18M.
  • Oppenheimer & Co fully exited Xilinx Inc in Q1 2022, selling an estimated $7.92M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.55B portfolio in Q1 2022.
  • Oppenheimer & Co opened 142 new positions and closed 164 in Q1 2022.
  • Oppenheimer & Co's portfolio value fell 3% quarter-over-quarter to $5.55B.

Based on Oppenheimer & Co's 13F filing for Q1 2022, filed 12 May 2022.